Wockhardt Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 10:19 am

Competitors of Wockhardt Ltd

All Competitor Stocks of Wockhardt Ltd

Quarterly Result

Last Updated: August 20, 2025, 1:10 am

Below is a detailed analysis of the quarterly data for Wockhardt Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 738.00 Cr.. The value appears to be declining and may need further review. It has decreased from 743.00 Cr. (Mar 2025) to 738.00 Cr., marking a decrease of 5.00 Cr..
• For Expenses, as of Jun 2025, the value is 666.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 679.00 Cr. (Mar 2025) to 666.00 Cr., marking a decrease of 13.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 72.00 Cr.. The value appears strong and on an upward trend. It has increased from 64.00 Cr. (Mar 2025) to 72.00 Cr., marking an increase of 8.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 9.00% (Mar 2025) to 10.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is -77.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to -77.00 Cr., marking a decrease of 92.00 Cr..
• For Interest, as of Jun 2025, the value is 48.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 48.00 Cr..
• For Depreciation, as of Jun 2025, the value is 56.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 53.00 Cr. (Mar 2025) to 56.00 Cr., marking an increase of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -109.00 Cr.. The value appears to be declining and may need further review. It has decreased from -22.00 Cr. (Mar 2025) to -109.00 Cr., marking a decrease of 87.00 Cr..
• For Tax %, as of Jun 2025, the value is -1.00%. The value appears to be improving (decreasing) as expected. It has decreased from 105.00% (Mar 2025) to -1.00%, marking a decrease of 106.00%.
• For Net Profit, as of Jun 2025, the value is -108.00 Cr.. The value appears to be declining and may need further review. It has decreased from -45.00 Cr. (Mar 2025) to -108.00 Cr., marking a decrease of 63.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -5.54. The value appears to be declining and may need further review. It has decreased from -1.54 (Mar 2025) to -5.54, marking a decrease of 4.00.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:08 am

Growth

Last Updated: September 5, 2025, 1:56 pm

Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Wockhardt Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -3.02. This value is below the healthy minimum of 5. It has increased from -32.05 (Mar 24) to -3.02, marking an increase of 29.03.
• For Diluted EPS (Rs.), as of Mar 25, the value is -3.02. This value is below the healthy minimum of 5. It has increased from -32.05 (Mar 24) to -3.02, marking an increase of 29.03.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.88. This value is within the healthy range. It has increased from -16.17 (Mar 24) to 9.88, marking an increase of 26.05.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 268.70. It has increased from 237.79 (Mar 24) to 268.70, marking an increase of 30.91.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 268.70. It has increased from 237.79 (Mar 24) to 268.70, marking an increase of 30.91.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 185.93. It has increased from 181.69 (Mar 24) to 185.93, marking an increase of 4.24.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 28.09. This value is within the healthy range. It has increased from 7.92 (Mar 24) to 28.09, marking an increase of 20.17.
• For PBIT / Share (Rs.), as of Mar 25, the value is 14.69. This value is within the healthy range. It has increased from -6.56 (Mar 24) to 14.69, marking an increase of 21.25.
• For PBT / Share (Rs.), as of Mar 25, the value is -0.98. This value is below the healthy minimum of 0. It has increased from -27.27 (Mar 24) to -0.98, marking an increase of 26.29.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -3.52. This value is below the healthy minimum of 2. It has increased from -30.65 (Mar 24) to -3.52, marking an increase of 27.13.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -2.90. This value is below the healthy minimum of 2. It has increased from -30.06 (Mar 24) to -2.90, marking an increase of 27.16.
• For PBDIT Margin (%), as of Mar 25, the value is 15.10. This value is within the healthy range. It has increased from 4.36 (Mar 24) to 15.10, marking an increase of 10.74.
• For PBIT Margin (%), as of Mar 25, the value is 7.90. This value is below the healthy minimum of 10. It has increased from -3.60 (Mar 24) to 7.90, marking an increase of 11.50.
• For PBT Margin (%), as of Mar 25, the value is -0.53. This value is below the healthy minimum of 10. It has increased from -15.01 (Mar 24) to -0.53, marking an increase of 14.48.
• For Net Profit Margin (%), as of Mar 25, the value is -1.89. This value is below the healthy minimum of 5. It has increased from -16.86 (Mar 24) to -1.89, marking an increase of 14.97.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is -1.56. This value is below the healthy minimum of 8. It has increased from -16.54 (Mar 24) to -1.56, marking an increase of 14.98.
• For Return on Networth / Equity (%), as of Mar 25, the value is -1.07. This value is below the healthy minimum of 15. It has increased from -13.78 (Mar 24) to -1.07, marking an increase of 12.71.
• For Return on Capital Employeed (%), as of Mar 25, the value is 3.90. This value is below the healthy minimum of 10. It has increased from -2.07 (Mar 24) to 3.90, marking an increase of 5.97.
• For Return On Assets (%), as of Mar 25, the value is -0.57. This value is below the healthy minimum of 5. It has increased from -6.05 (Mar 24) to -0.57, marking an increase of 5.48.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has increased from 0.26 (Mar 24) to 0.27, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.62 (Mar 24) to 0.42, marking a decrease of 0.20.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.38. It has increased from 0.36 (Mar 24) to 0.38, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 1.26. This value is below the healthy minimum of 1.5. It has increased from 0.78 (Mar 24) to 1.26, marking an increase of 0.48.
• For Quick Ratio (X), as of Mar 25, the value is 0.90. This value is below the healthy minimum of 1. It has increased from 0.55 (Mar 24) to 0.90, marking an increase of 0.35.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.41. This value is within the healthy range. It has increased from 0.95 (Mar 24) to 4.41, marking an increase of 3.46.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.79. This value is below the healthy minimum of 3. It has increased from 0.40 (Mar 24) to 1.79, marking an increase of 1.39.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 3. It has increased from -0.50 (Mar 24) to 0.77, marking an increase of 1.27.
• For Enterprise Value (Cr.), as of Mar 25, the value is 25,036.75. It has increased from 10,872.67 (Mar 24) to 25,036.75, marking an increase of 14,164.08.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 8.31. This value exceeds the healthy maximum of 3. It has increased from 3.89 (Mar 24) to 8.31, marking an increase of 4.42.
• For EV / EBITDA (X), as of Mar 25, the value is 55.03. This value exceeds the healthy maximum of 15. It has decreased from 89.12 (Mar 24) to 55.03, marking a decrease of 34.09.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 7.66. This value exceeds the healthy maximum of 3. It has increased from 3.21 (Mar 24) to 7.66, marking an increase of 4.45.
• For Price / BV (X), as of Mar 25, the value is 5.30. This value exceeds the healthy maximum of 3. It has increased from 2.68 (Mar 24) to 5.30, marking an increase of 2.62.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 7.66. This value exceeds the healthy maximum of 3. It has increased from 3.21 (Mar 24) to 7.66, marking an increase of 4.45.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -0.05 (Mar 24) to 0.00, marking an increase of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness